Investor Alert

Syneos Health Inc. Cl A



After Hours

 --Quotes are delayed by 20 min

Sep 25, 2020, 4:00 p.m.





0.00 0.00%


Volume 302,013

Quotes are delayed by 20 min


Previous close

$ 51.29

$ 51.58


+0.29 +0.57%

Day low

Day high




52 week low

52 week high




Annual Financials for Syneos Health Inc. Cl A

Operating Activities

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Net Income before Extraordinaries 117.05M112.63M(138.47M)24.28M131.26M
Depreciation, Depletion & Amortization 56.01M59.2M179.94M273.69M242.47M
Depreciation and Depletion 18.14M21.35M44.41M72.16M76.53M
Amortization of Intangible Assets 37.87M37.85M135.53M201.53M165.93M
Deferred Taxes & Investment Tax Credit 4.13M(22.26M)14.43M240,000(40.07M)
Deferred Taxes 4.13M(22.26M)14.43M240,000(40.07M)
Investment Tax Credit -----
Other Funds 19.79M38.97M95.33M5.92M77.89M
Funds from Operations 196.98M188.54M151.23M304.13M411.54M
Extraordinaries -----
Changes in Working Capital 7.76M(79.21M)47.03M(3.74M)(93.06M)
Receivables (54.07M)(103.75M)31.66M(97.62M)(120.39M)
Accounts Payable 8.19M6.66M(16.98M)60.02M28.32M
Other Assets/Liabilities 53.65M17.88M32.35M33.85M(987,000)
Net Operating Cash Flow 204.74M109.33M198.26M300.39M318.48M

Investing Activities

20152016201720182019 5-year trend
Capital Expenditures (21.11M)(31.35M)(43.9M)(54.6M)(63.97M)
Capital Expenditures (Fixed Assets) (21.11M)(31.35M)(43.9M)(54.6M)(63.97M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions --(1.68B)(90.89M)(712,000)
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments ----(16.98M)
Purchase of Investments ----(16.98M)
Sale/Maturity of Investments -----
Other Uses --(197,000)--
Other Sources -----
Net Investing Cash Flow (21.11M)(31.35M)(1.72B)(145.49M)(81.66M)

Financing Activities

20152016201720182019 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock (282.77M)(46.61M)19.34M(53.16M)(16.39M)
Repurchase of Common & Preferred Stk. (286.42M)(64.5M)-(74.99M)(56.72M)
Sale of Common & Preferred Stock 3.66M17.89M19.34M21.82M40.32M
Proceeds from Stock Options -----
Other Proceeds from Sale of Stock 3.66M17.89M19.34M21.82M40.32M
Issuance/Reduction of Debt, Net 74.56M(5.87M)1.72B(406.07M)(291.18M)
Change in Current Debt -----
Change in Long-Term Debt 74.56M(5.87M)1.72B(406.07M)(291.18M)
Issuance of Long-Term Debt 565.01M99.13M2.59B-579.36M
Reduction in Long-Term Debt (490.45M)(105M)(865.67M)(406.07M)(870.54M)
Other Funds (3.19M)(839,000)(6.82M)142.94M92.1M
Other Uses (4.17M)(839,000)(6.82M)(44.76M)(35.71M)
Other Sources 975,000--187.7M127.82M
Net Financing Cash Flow (211.4M)(53.32M)1.73B(316.29M)(215.47M)
Exchange Rate Effect (13.67M)(7.2M)9.07M(4.65M)(13.59M)
Miscellaneous Funds -----
Net Change in Cash (41.44M)17.46M218.79M(166.04M)7.76M
Free Cash Flow 183.63M77.98M154.36M245.79M254.51M
Link to MarketWatch's Slice.